Table 1.
Clinical characteristics of the leprosy patients enrolled in this study.
| Leprosy classification (n, %) | Leprosy reactions (n, %) | Leprosy disability (n, %) | Leprosy treatment duration (n, %) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| WHO* | RJ** | Type 1 | Type 2 | NR | ND | D | SD | LD | ||
| MB | 37(52.1) | LL | 23(62.2) | 0(0) | 3(60) | 20(31.7) | 11(37.9) | 12(28.6) | 5(27.8) | 18(34.0) |
| BL | 8(21.6) | 0(0) | 2(40) | 6(9.5) | 7(24.1) | 1(2.4) | 5(27.8) | 3(5.7) | ||
| BB | 6(16.2) | 1(33.3) | 0(0) | 5(7.9) | 5(17.2) | 1(2.4) | 2(11.1) | 4(7.5) | ||
| PB | 34(47.9) | BT | 8(23.5) | 1(33.3) | 0(0) | 7(11.1) | 4(13.8) | 4(9.5) | 5(27.8) | 3(5.7) |
| TT | 26(76.5) | 1(33.3) | 0(0) | 25(39.7) | 2(6.9) | 24(57.1) | 1(5.5) | 25(47.1) | ||
| Total | 71(100) | 71(100) | 3(100) | 5(100) | 63(100) | 29(100) | 42(100) | 18(100) | 53(100) | |
n: number of patients, with percentages in parentheses. *WHO: Operational classification proposed by the World Health Organization. **RJ: Ridley-Jopling classification. NR: no reaction; ND: no disability; D: disability.